Detailed answers about TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED founded?
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED was officially incorporated on 29 December 2015 and is registered under company number 09930195. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED?
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED do?
TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED operates in the following sectors: 72110 - Research and experimental development on biotechnology, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED's registered address?
The registered office address of TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED is 2 HINKSEY COURT, CHURCH WAY, OXFORD, ENGLAND, OX2 9SX. This is the official address filed with Companies House for legal and statutory correspondence.
Is TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED financially stable?
The most recent accounts for TAILORED CLINICAL RESEARCH SOLUTIONS LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.